[1]
Yan CH, Hwang PH. Surgical Management of Nonallergic Rhinitis. Otolaryngologic clinics of North America. 2018 Oct:51(5):945-955. doi: 10.1016/j.otc.2018.05.010. Epub 2018 Jun 22
[PubMed PMID: 29937065]
[2]
Bernstein JA. Nonallergic rhinitis: therapeutic options. Current opinion in allergy and clinical immunology. 2013 Aug:13(4):410-6. doi: 10.1097/ACI.0b013e3283630cd8. Epub
[PubMed PMID: 23756873]
Level 3 (low-level) evidence
[3]
Joe SA. Nonallergic rhinitis. Facial plastic surgery clinics of North America. 2012 Feb:20(1):21-30. doi: 10.1016/j.fsc.2011.10.003. Epub
[PubMed PMID: 22099614]
[4]
Shaari CM, Sanders I, Wu BL, Biller HF. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 1995 Apr:112(4):566-71
[PubMed PMID: 7700663]
[5]
Ozcan C, Ismi O. Botulinum Toxin for Rhinitis. Current allergy and asthma reports. 2016 Aug:16(8):58. doi: 10.1007/s11882-016-0636-3. Epub
[PubMed PMID: 27461136]
[6]
Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clinical allergy and immunology. 2007:19():23-34
[PubMed PMID: 17153005]
[7]
Settipane RA, Lieberman P. Update on nonallergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2001 May:86(5):494-507; quiz 507-8
[PubMed PMID: 11379801]
[8]
Lund VJ, Preziosi P, Hercberg S, Hamoir M, Dubreuil C, Pessey JJ, Stoll D, Zanaret M, Gehanno P. Yearly incidence of rhinitis, nasal bleeding, and other nasal symptoms in mature women. Rhinology. 2006 Mar:44(1):26-31
[PubMed PMID: 16550946]
[9]
Kaliner MA. Classification of Nonallergic Rhinitis Syndromes With a Focus on Vasomotor Rhinitis, Proposed to be Known henceforth as Nonallergic Rhinopathy. The World Allergy Organization journal. 2009 Jun 15:2(6):98-101. doi: 10.1097/WOX.0b013e3181a9d55b. Epub 2009 Jun 15
[PubMed PMID: 24229372]
[10]
Pattanaik D, Lieberman P. Vasomotor rhinitis. Current allergy and asthma reports. 2010 Mar:10(2):84-91. doi: 10.1007/s11882-010-0089-z. Epub
[PubMed PMID: 20425499]
[11]
Meggs WJ, Cleveland CH Jr. Rhinolaryngoscopic examination of patients with the multiple chemical sensitivity syndrome. Archives of environmental health. 1993 Jan-Feb:48(1):14-8
[PubMed PMID: 8452394]
[12]
Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. The Journal of allergy and clinical immunology. 2006 Nov:118(5):985-98
[PubMed PMID: 17088121]
[13]
Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2006 Apr:96(4):526-32
[PubMed PMID: 16680922]
[14]
Gosepath J, Amedee RG, Mann WJ. Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. The Laryngoscope. 2005 Mar:115(3):512-6
[PubMed PMID: 15744168]
[15]
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D, World Health Organization, GA(2)LEN, AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr:63 Suppl 86():8-160. doi: 10.1111/j.1398-9995.2007.01620.x. Epub
[PubMed PMID: 18331513]
[16]
Rosenfeld RM. CLINICAL PRACTICE. Acute Sinusitis in Adults. The New England journal of medicine. 2016 Sep 8:375(10):962-70. doi: 10.1056/NEJMcp1601749. Epub
[PubMed PMID: 27602668]
[17]
Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. The New England journal of medicine. 1987 Jun 11:316(24):1506-10
[PubMed PMID: 2438553]
[18]
Cervin A, Andersson M. Intranasal steroids and septum perforation--an overlooked complication? A description of the course of events and a discussion of the causes. Rhinology. 1998 Sep:36(3):128-32
[PubMed PMID: 9830677]
[19]
Webb DR, Meltzer EO, Finn AF Jr, Rickard KA, Pepsin PJ, Westlund R, Cook CK. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2002 Apr:88(4):385-90
[PubMed PMID: 11995670]
[20]
Synnerstad B, Lindqvist N. A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: a 12 month study. The British journal of clinical practice. 1996 Oct-Nov:50(7):363-6
[PubMed PMID: 9015907]
[21]
Creticos P, Fireman P, Settipane G, Bernstein D, Casale T, Schwartz H. Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group. Allergy and asthma proceedings. 1998 Sep-Oct:19(5):285-94
[PubMed PMID: 9801742]
[22]
Wight RG, Jones AS, Beckingham E, Andersson B, Ek L. A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis. Clinical otolaryngology and allied sciences. 1992 Aug:17(4):354-8
[PubMed PMID: 1526057]
Level 1 (high-level) evidence
[23]
Grossman J, Banov C, Boggs P, Bronsky EA, Dockhorn RJ, Druce H, Findlay SR, Georgitis JW, Hampel FC, Kaiser H. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. The Journal of allergy and clinical immunology. 1995 May:95(5 Pt 2):1123-7
[PubMed PMID: 7538520]
[24]
Bronsky EA, Druce H, Findlay SR, Hampel FC, Kaiser H, Ratner P, Valentine MD, Wood CC. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. The Journal of allergy and clinical immunology. 1995 May:95(5 Pt 2):1117-22
[PubMed PMID: 7751528]
[25]
Lieberman PL, Settipane RA. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. Allergy and asthma proceedings. 2003 Mar-Apr:24(2):95-105
[PubMed PMID: 12776442]
[26]
Lieberman P. Intranasal antihistamines for allergic rhinitis: mechanism of action. Allergy and asthma proceedings. 2009 Jul-Aug:30(4):345-8. doi: 10.2500/aap.2009.30.3263. Epub
[PubMed PMID: 19772756]
[27]
Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2001 Jan:86(1):28-35
[PubMed PMID: 11206234]
[28]
Lieberman P, Kaliner MA, Wheeler WJ. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Current medical research and opinion. 2005 Apr:21(4):611-8
[PubMed PMID: 15899111]
Level 3 (low-level) evidence
[29]
Luo X, Ma R, Wu X, Xian D, Li J, Mou Z, Li H. Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2015 May:272(5):1165-73. doi: 10.1007/s00405-014-3191-3. Epub 2014 Jul 25
[PubMed PMID: 25060977]
[30]
Fokkens W, Hellings P, Segboer C. Capsaicin for Rhinitis. Current allergy and asthma reports. 2016 Aug:16(8):60. doi: 10.1007/s11882-016-0638-1. Epub
[PubMed PMID: 27485456]
[31]
Gevorgyan A, Segboer C, Gorissen R, van Drunen CM, Fokkens W. Capsaicin for non-allergic rhinitis. The Cochrane database of systematic reviews. 2015 Jul 14:(7):CD010591. doi: 10.1002/14651858.CD010591.pub2. Epub 2015 Jul 14
[PubMed PMID: 26171907]
Level 1 (high-level) evidence
[32]
Lockey RF. Rhinitis medicamentosa and the stuffy nose. The Journal of allergy and clinical immunology. 2006 Nov:118(5):1017-8
[PubMed PMID: 17088123]
[33]
Braun T, Gürkov R, Kramer MF, Krause E. Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study. American journal of otolaryngology. 2012 Jan-Feb:33(1):64-7. doi: 10.1016/j.amjoto.2011.01.004. Epub 2011 Mar 17
[PubMed PMID: 21419514]
Level 3 (low-level) evidence
[34]
Passàli D, Passàli FM, Damiani V, Passàli GC, Bellussi L. Treatment of inferior turbinate hypertrophy: a randomized clinical trial. The Annals of otology, rhinology, and laryngology. 2003 Aug:112(8):683-8
[PubMed PMID: 12940665]
Level 1 (high-level) evidence
[35]
Marshak T, Yun WK, Hazout C, Sacks R, Harvey RJ. A systematic review of the evidence base for vidian neurectomy in managing rhinitis. The Journal of laryngology and otology. 2016 Jul:130 Suppl 4():S7-S28. doi: 10.1017/S0022215116008008. Epub
[PubMed PMID: 27488341]
Level 1 (high-level) evidence
[36]
GOLDING-WOOD PH. Observations on petrosal and vidian neurectomy in chronic vasomotor rhinitis. The Journal of laryngology and otology. 1961 Mar:75():232-47
[PubMed PMID: 13706533]
[37]
Halderman A, Sindwani R. Surgical management of vasomotor rhinitis: a systematic review. American journal of rhinology & allergy. 2015 Mar-Apr:29(2):128-34. doi: 10.2500/ajra.2015.29.4141. Epub
[PubMed PMID: 25785754]
Level 1 (high-level) evidence
[38]
Ma Y, Tan G, Zhao Z, Li W, Huang L, Liu G. Therapeutic effectiveness of endoscopic vidian neurectomy for the treatment of vasomotor rhinitis. Acta oto-laryngologica. 2014 Mar:134(3):260-7. doi: 10.3109/00016489.2013.831478. Epub 2014 Jan 17
[PubMed PMID: 24433056]
[39]
Ellegård EK, Karlsson NG, Ellegård LH. Rhinitis in the menstrual cycle, pregnancy, and some endocrine disorders. Clinical allergy and immunology. 2007:19():305-21
[PubMed PMID: 17153022]
[40]
Berger WE, Schonfeld JE. Nonallergic rhinitis in children. Current allergy and asthma reports. 2007 May:7(2):112-6
[PubMed PMID: 17437681]
[41]
Greiwe J, Bernstein JA. Nonallergic Rhinitis: Diagnosis. Immunology and allergy clinics of North America. 2016 May:36(2):289-303. doi: 10.1016/j.iac.2015.12.006. Epub 2016 Mar 12
[PubMed PMID: 27083103]
[42]
Fokkens WJ. Thoughts on the pathophysiology of nonallergic rhinitis. Current allergy and asthma reports. 2002 May:2(3):203-9
[PubMed PMID: 11918861]
[43]
Ellegård EK. Pregnancy rhinitis. Immunology and allergy clinics of North America. 2006 Feb:26(1):119-35, vii
[PubMed PMID: 16443147]
[44]
Philpott CM, Robinson AM, Murty GE. Nasal pathophysiology and its relationship to the female ovarian hormones. Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale. 2008 Aug:37(4):540-6
[PubMed PMID: 19128590]
[45]
Hytönen M, Kanerva L, Malmberg H, Martikainen R, Mutanen P, Toikkanen J. The risk of occupational rhinitis. International archives of occupational and environmental health. 1997:69(6):487-90
[PubMed PMID: 9215937]
[46]
Pałczyński C, Walusiak J, Krakowiak A, Szymczak W, Wittczak T, Ruta U, Górski P. Nasal lavage fluid examination in diagnostics of occupational allergy to chloramine. International journal of occupational medicine and environmental health. 2003:16(3):231-40
[PubMed PMID: 14587536]
[47]
Rondón C, Doña I, Torres MJ, Campo P, Blanca M. Evolution of patients with nonallergic rhinitis supports conversion to allergic rhinitis. The Journal of allergy and clinical immunology. 2009 May:123(5):1098-102. doi: 10.1016/j.jaci.2009.02.018. Epub 2009 Apr 10
[PubMed PMID: 19361848]
[48]
Lieberman PL, Smith P. Nonallergic Rhinitis: Treatment. Immunology and allergy clinics of North America. 2016 May:36(2):305-19. doi: 10.1016/j.iac.2015.12.007. Epub 2016 Feb 26
[PubMed PMID: 27083104]
[49]
Rydén O, Andersson B, Andersson M. Disease perception and social behaviour in persistent rhinitis: a comparison between patients with allergic and nonallergic rhinitis. Allergy. 2004 Apr:59(4):461-4
[PubMed PMID: 15005772]
[50]
Levenson T, Greenberger PA. Pathophysiology and therapy for allergic and nonallergic rhinitis: an updated review. Allergy and asthma proceedings. 1997 Jul-Aug:18(4):213-20
[PubMed PMID: 9270882]
[51]
Hamizan AW, Azer M, Alvarado R, Earls P, Barham HP, Tattersall J, Rimmer J, Kalish L, Sewell WA, Harvey R. The Distinguishing Clinical Features of Nonallergic Rhinitis Patients. American journal of rhinology & allergy. 2019 Sep:33(5):524-530. doi: 10.1177/1945892419850750. Epub 2019 May 20
[PubMed PMID: 31106562]